Could some one tell me if we are retaining the shares we have in gsk at present and top of it ,we are getting extra shares in the new company is this correct
What conclusion would be for provexis as we are coming to the end of first half ( june tomorrow)or by end of 2022 ,would we be bought out by Dsm or Byhealth ,or would we just renew kour contract terms
Could some one please explain ,how is the split going to effect the share holders, as earlier rns stated they are stopping from issuing any more certificates